ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

December 13, 1996

L-PAM, Less Than Radical Surgery Results Holding Up, New Breast Cancer Studies Sought

September 12, 1975

FASEB Urges 6.7 Percent Increase In NIH Budget.

February 1, 2008

Text of PDQ Statement on Breast Screening

September 17, 1993

PET Response Can Predict Increased Survival In Patients

April 27, 2012

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

June 27, 2014